Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hakan Harputluoglu

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2007
Erectile dysfunction in successfully treated lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Medical Oncology (Northwood, London, England)|April 17, 2008
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphomaSaadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, et al.
Breast (Edinburgh, Scotland)|August 30, 2011
Breast cancer subtypes and outcomes of central nervous system metastasesUlku Y Arslan, Berna Oksuzoglu, Sercan Aksoy, et al.
Annals of Hematology|September 18, 2007
Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significanceOmer Dizdar, Mustafa Erman, Mustafa Cankurtaran, et al.
Journal of the National Medical Association|May 30, 2008
Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Onkologie|December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experienceBulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2007
Erectile dysfunction in successfully treated lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Medical Oncology (Northwood, London, England)|April 17, 2008
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphomaSaadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, et al.
Breast (Edinburgh, Scotland)|August 30, 2011
Breast cancer subtypes and outcomes of central nervous system metastasesUlku Y Arslan, Berna Oksuzoglu, Sercan Aksoy, et al.
Annals of Hematology|September 18, 2007
Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significanceOmer Dizdar, Mustafa Erman, Mustafa Cankurtaran, et al.
Journal of the National Medical Association|May 30, 2008
Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Onkologie|December 5, 2012
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experienceBulent Cetin, Mustafa Benekli, Berna Oksuzoglu, et al.
Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
Pageof 4